Hyundai Bio Land Reports Record High Cumulative Operating Profit of 13.6 Billion KRW in Q3

Hyundai BioLand achieved record-high cumulative sales and operating profit for the first to third quarters of this year.

Hyundai BioLand, a comprehensive healthcare company affiliated with Hyundai Department Store Group, announced on the 31st that its cumulative sales for the first to third quarters of this year were tentatively estimated at 98 billion KRW, a 24.8% increase compared to the previous year.

Operating profit for the same period increased by 47.3% to 13.6 billion KRW. Both sales and operating profit represent the highest cumulative results for the first three quarters in the company's history.

Third-quarter sales also reached 33.5 billion KRW, marking the highest quarterly performance ever, with operating profit rising 54.1% to 3.4 billion KRW.

Hyundai BioLand also disclosed a mid-to-long-term dividend policy on the same day, aiming to distribute more than 10% of operating profit (on a separate basis) as dividends over the next three years until 2026 to enhance dividend predictability and shareholder value.

A Hyundai BioLand representative stated, "With the expansion of domestic and international sales in existing business sectors such as cosmetics and health functional food materials, along with the strong performance of the new health food distribution business launched in collaboration with global healthcare company Nestl? Health Science, we have achieved record-high cumulative sales and operating profit."

This content was produced with the assistance of AI translation services.